解码介质干细胞在调节癌症干细胞和耐药性的秘密作用
Sameer Kumar Panda1, Nirmal Robinson2, Vincenzo Desiderio3
1Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples 80138, Italy; Center for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA 5001, Australia.
Biochimica et biophysica acta. Reviews on cancer
|October 31, 2024
概括
抗药性在癌症治疗中是一个主要障碍. 本综述探讨了瘤微环境 (TME) 中的介质干细胞 (MSC) 如何调节癌症干细胞 (CSC) 和流体载体,提供了一种新的治疗方法.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 干细胞研究 干细胞研究
背景情况:
- 药物耐药性,特别是通过像P-gp/ABCB1这样的排泄载体介导的耐药性,显著阻碍了有效的癌症化疗.
- 尽管流量载体抑制剂的进步,但完全抑制仍然难以捉摸,突出需要替代策略.
- 癌症干细胞 (CSCs) 导致瘤复发,并且由于它们的休眠状态,它们本质上对传统治疗有抗性.
研究的目的:
- 审查介质干细胞 (MSC) 在瘤微环境 (TME) 中的调控作用.
- 阐明MSCs影响CSC和流量输送器活动的机制.
- 提出一种针对MSCs的新型治疗策略,以克服化学抵抗和CSC介导的复发.
主要方法:
- 文献综述侧重于MSCs,CSCs和TME内的排放输送器之间的相互作用.
- 对TME在癌症药物耐药性中的作用现有研究的分析.
- 综合发现,提出一个新的治疗范式.
主要成果:
- 介酶干细胞 (MSC) 被确定为瘤微环境 (TME) 中的关键调节者.
- MSCs影响癌症干细胞 (CSCs) 的行为和流体输送体的表达/活动.
- MSCs,CSCs和流量载体之间的相互作用是克服治疗耐药性的关键目标.
结论:
- 向介质干细胞 (MSCs) 为打击癌症抗药性提供了一个有希望的新途径.
- 了解MSC介导的CSC和流量输送器的调节对于开发有效的癌症疗法至关重要.
- 专注于调节MSC的治疗方法可能会解决治疗耐药性和癌症复发的问题.
更多相关视频
07:03Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Published on: October 2, 2020
4.5K
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10.2K
相关概念视频
02:40Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
01:19Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:18Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
3.4K
A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
3.4K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K